Production (Stage)
Deltex Medical Group plc
DTXMF
$0.0952
$0.09223,073.33%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 2.63M | 2.44M | 2.24M | 2.24M | 2.21M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.63M | 2.44M | 2.24M | 2.24M | 2.21M |
| Cost of Revenue | 840.30K | 843.70K | 847.80K | 832.30K | 809.50K |
| Gross Profit | 1.79M | 1.59M | 1.40M | 1.40M | 1.40M |
| SG&A Expenses | 2.05M | 2.01M | 1.96M | 2.09M | 2.19M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 20.60K | -71.60K | -165.60K | -190.60K | -214.90K |
| Total Operating Expenses | 3.69M | 3.42M | 3.14M | 3.12M | 3.06M |
| Operating Income | -1.06M | -978.60K | -896.40K | -878.60K | -851.60K |
| Income Before Tax | -2.31M | -1.97M | -1.63M | -1.62M | -1.60M |
| Income Tax Expenses | -- | -600.00 | -1.20K | -600.00 | 0.00 |
| Earnings from Continuing Operations | -2.31 | -1.97 | -1.62 | -1.62 | -1.60 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.31M | -1.97M | -1.62M | -1.62M | -1.60M |
| EBIT | -1.06M | -978.60K | -896.40K | -878.60K | -851.60K |
| EBITDA | -989.80K | -901.50K | -818.20K | -801.20K | -775.80K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 7.57B | 7.34B | 7.10B | 5.91B | 4.72B |
| Average Diluted Shares Outstanding | 7.57B | 7.34B | 7.10B | 5.91B | 4.72B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |